Overview
- The NordICC study followed more than 84,000 adults for 13 years and saw a 19% drop in colorectal cancer incidence among those invited to colonoscopy, while deaths were 0.41% versus 0.47% in usual care.
- Only 42% of people invited actually had a colonoscopy, which diluted the observed effect and led researchers to estimate incidence could fall by about 45% with full participation.
- Investigators and clinicians flagged differences in bowel prep, scope quality, and operator experience across Poland, Norway, and Sweden that can change how well screening works.
- In the screening group, only 16% of cancers were found by a colonoscopy or other early test, which suggests many people delayed testing until symptoms appeared.
- Specialists still advise routine screening starting around age 50 for average-risk adults and point to fecal blood tests as a less invasive option for those who avoid colonoscopy.